ZNF702P expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.098600E-01
Normal-vs-Stage2
8.181800E-01
Normal-vs-Stage3
2.133800E-01
Normal-vs-Stage4
4.490800E-01
Stage1-vs-Stage2
3.087600E-01
Stage1-vs-Stage3
8.640000E-02
Stage1-vs-Stage4
5.217600E-01
Stage2-vs-Stage3
1.600200E-01
Stage2-vs-Stage4
6.334100E-02
Stage3-vs-Stage4
7.452300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.434000E-01
Normal-vs-AfricanAmerican
8.790200E-01
Normal-vs-Asian
7.903200E-01
Caucasian-vs-AfricanAmerican
4.318800E-01
Caucasian-vs-Asian
9.849200E-01
AfricanAmerican-vs-Asian
5.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.172000E-01
Normal-vs-Female
9.099600E-01
Male-vs-Female
3.421800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.763400E-01
Normal-vs-Age(41-60Yrs)
9.866000E-01
Normal-vs-Age(61-80Yrs)
6.774200E-01
Normal-vs-Age(81-100Yrs)
5.870000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.953000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.489400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.590600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.061000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.846400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.371000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.214800E-01
Normal-vs-Daily Drinker
5.951400E-01
Normal-vs-Weekly Drinker
4.888400E-01
Normal-vs-Occasional Drinker
9.496400E-01
Normal-vs-Social Drinker
5.673400E-01
Non Drinker-vs-Daily Drinker
9.103800E-01
Non Drinker-vs-Weekly Drinker
7.092600E-01
Non Drinker-vs-Occasional Drinker
9.259600E-02
Non Drinker-vs-Social Drinker
6.991600E-01
Daily Drinker-vs-Weekly Drinker
8.372600E-01
Daily Drinker-vs-Occasional Drinker
2.267000E-01
Daily Drinker-vs-Social Drinker
8.419800E-01
Weekly Drinker-vs-Occasional Drinker
2.401200E-01
Weekly Drinker-vs-Social Drinker
9.784600E-01
Occasional Drinker-vs-Social Drinker
2.725000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.004200E-01
Normal-vs-Grade 2
8.791700E-02
Normal-vs-Grade 3
9.213900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.130200E-01
Grade 1-vs-Grade 3
7.772600E-01
Grade 1-vs-Grade 4
2.004200E-01
Grade 2-vs-Grade 3
8.159800E-01
Grade 2-vs-Grade 4
8.791700E-02
Grade 3-vs-Grade 4
9.213900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.704800E-01
Normal-vs-NonDiabetic
7.667400E-01
Diabetic-vs-NonDiabetic
1.386800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.181600E-01
Normal-vs-NoPancreatitis
7.211800E-01
Pancreatitis-vs-NoPancreatitis
8.788200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.602200E-01
Normal-vs-N1
8.766800E-01
N0-vs-N1
1.605190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.045800E-01
Normal-vs-TP53-NonMutant
8.419400E-01
TP53-Mutant-vs-TP53-NonMutant
4.580200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
